Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2017 December;59(4) > Panminerva Medica 2017 December;59(4):302-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Panminerva Medica 2017 December;59(4):302-7

DOI: 10.23736/S0031-0808.16.03236-5

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis

Hong CHEN 1, Nan HU 2, Peng CHANG 1, Tao KANG 1, Song HAN 1, Yaoliang LU 1 , Maoquan LI 2

1 Department of General Surgery, Taicang Hospital Affiliated to Soochow University, Taicang, Jiangsu, China; 2 Department of Vascular Surgery, Shanghai Tenth People’s Hospital Affiliated to Tongji University, Shanghai, China


PDF


INTRODUCTION: Hepatocellular carcinoma (HCC) is the fifth-most common cancer. Recent studies have demonstrated that there was a relationship between modified Glasgow prognostic score (mGPS) and survival of HCC. However, the results were inconsistent.
EVIDENCE ACQUISITION: The following databases were searched for relevant articles published until June 2016: PubMed; EMBASE; Web of Science and the China National Knowledge Infrastructure. The strength of association between mGPS and OS of HCC was estimated by pooled HRs with corresponding 95% CIs.
EVIDENCE SYNTHESIS: Seven studies with 2047 HCC patients were included in this meta-analysis. The mGPS was an independent marker of poor prognosis in patients with HCC (HR=2.21; 95% CI: 1.73-2.82; I2=51%). In the subgroup analysis of study design, both prospective studies (HR=1.68; 95% CI: 1.35-2.11; I2=0%) and retrospective studies (HR=2.64; 95% CI: 1.92-3.62; I2=39%) with higher mGPS had shorter OS. The patients with resectable HCC and high mGPS also showed shorter OS (HR=2.33; 95% CI: 1.65-3.29; I2=63%). In the subgroup analysis by sample size, both large sample size studies (HR=2.56; 95% CI: 1.50-4.38; I2=72%) and small sample size studies (HR=2.00; 95% CI: 1.62-2.48; I2=0%) showed the same results.
CONCLUSIONS: In conclusion, this meta-analysis suggested that mGPS might be an independent prognostic factor for HCC.


KEY WORDS: Carcinoma, hepatocellular - Meta-analysis as topic - Survival

top of page